A metabolic approach to the treatment of dilated cardiomyopathy in BIO T0-2 cardiomyopathic Syrian hamsters

BioFactors

Volumn 25, Issue 1-4, 2005, Pages 127-135

  Mancinelli, Rino ^a   Vargiu, Romina ^a   Cappai, Antonello ^a   Floris, Giuseppe ^a   Fraschini, Matteo ^a   Faa, Gavino ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

BIO T0 2 Syrian hamster; Coenzyme Q10; Dilated cardiomyopathy; Omega 3 fatty acids; Propionyl L carnitine

Indexed keywords

HS 12607; OMEGA 3 FATTY ACID; PROPIONYLCARNITINE; UBIDECARENONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; COMPARATIVE STUDY; CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; DYNAMICS; ELECTRON MICROSCOPY; FORCE; HAMSTER; HEART PAPILLARY MUSCLE; HEART VENTRICLE WALL; MALE; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; SARCOMERE LENGTH; STARLING LAW; STRUCTURE ANALYSIS;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 33746053228     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520250114     Document Type: Conference Paper

References (16)

1. H. Ashrafian, Cardiac energetics in congestive heart failure, Circulation 105 (2002), e44-e45.
2. R. Fato, S. Estornel, E.F. Di Bernardo, G. Pallotti, G. Parenti Castelli and G. Lenaz, Steady-state Kinetics of the reduction of coenzyme Q analogs by complex I (NADH: ubiquinone oxidoreductase) in bovine hearth mitochondria and submitochondrial particles, Biochemistry 35 (1996), 2705-2716.
3. R. Ferrari, E. Pasini, E. Condorelli, A. Boraso, R. Lisciani, A. Marzo and O. Visioli, Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart, Cardiovasc Drugs Therapy 5 (1991), 17-24.
4. A.M. Katz, Mechanism and abnormalities of contractility and relaxation in the failing heart, Cardiologia 38 (1993), 39-43.
5. M.E. Keith, A. Ball, K.N. Jeejeebhoy, R. Kurian, J. Butany, F. Dawood, W.H. Wen, A. Madapallimattam and M.J. Sole, Conditioned nutritional deficiencies in the cardiomyopathic hamster heart, Can J Cardiol 17 (2001), 449-458.
6. A.J. Liedtke, S.H. Nellis and O.D. Mjos, Effects of reducing fatty acid metabolism on mechanical function in regionally ischemic hearts, Am J Physiol 247 (1984), H387-H394.
7. P. Maresca, R. Mancinelli, N. Corsico, E. Arrigoni-Martelli and E. Manni, Positive action of propionyl-L-carnitine on mechanical performance of papillary muscle from Syrian hamsters with hereditary dilated cardiomyopathy, Eur J Pharmacol 287 (1995), 303-307.
8. R. Micheletti, E.D. Di Paola, A. Schiavone, E. English, P. Benfatti, J.M. Papasso, P. Anversa and G. Bianchi, Propionyl-L-carnitine limits chronics ventricular dilation after myocardial infarction in rats, Am J Physiol 264 (1993), 1111-1117.
9. 10 (ubiquinone), Clin Investig 71 (1993), S116-S123.
10. J.A. Paige, R. Liao, R.J. Hajjar, L.F. Rebecca, C.R. Cory, P.J. O'Brien and J.K. Gwathmey, Effect of a high omega-3 fatty acid diet on cardiac contractile performance in Oncorhynchus mykiss, Cardiovasc Res 31 (1996), 249-262.
11. 10 in congestive cardiomyopathy, Am J Ther 4 (1997), 66-72.
12. R.H. Schwinger, M. Bohm, A. Koch, U. Schmidt, I. Morano, H.J. Eissner, P. Uberfuhr, B. Reichart and E. Erdmann, The failing human heart is unable to use the Frank-Starling mechanism, Circ Res 74 (1994), 959-969.
13. N. Siliprandi, F. Di Lisa and R. Menabò, PLC: biochemical significance and possible role in cardiac metabolism, Cardiovasc Drugs Ther 1 (1991), 11-15.
14. 10, nicotinamide, riboflavin and pantothenic acid in the rat, Physiol Behav 76 (2001), 257-263.
15. R. Ventura-Clapier, A. Garnier and V. Veksler, Energy metabolism in heart failure, J Physiol 1 (2004), 555 1-13.
16. J.T. Whitmer, P. Cumar and R.J. Solaro, Calcium transport properties of cardiac sarcoplasmic reticulum from cardiomyopathic Syrian hamsters (BIO 53.58 and 14.6): evidence for a quantitative defect in dilated myopathic hearts not evident in hypertrophic hearts, Circ Res 62 (1988), 1 81-85.